CNS Pharmaceuticals, Inc.

CIK: 1729427NVIncorporated: 2017-07-27

Current Offering

$100,000
Target Amount
$1,070,000
Maximum Amount
2018-06-11
Deadline

Security Details

Type: Units of SAFE (Simple Agreement for Future Equity)
Price per share: $1.00
Shares offered: 100,000+

Offering Costs

Cash commission: 5%
5.0% of the amount raised and 2% of the Securities being issued in this Offering
Equity compensation: 2%
If offering is successful, intermediary will receive a commission equivalent to 2% of the Securities being issued in this Offering

Financial Reports

Offering via Republic

Offering History

As of 2018-03-13
Raising $100,000 -$1,070,000 via 100,000+ shares of units of SAFE (Simple Agreement for Future Equity) at $1.00 per share
Deadline: 2018-06-11
As of 2018-06-15
Raising $100,000 -$1,070,000 via 100,000+ shares of units of SAFE (Simple Agreement for Future Equity) at $1.00 per share
Deadline: 2018-06-11
Filing date2018-03-13
Current employees4
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$110,543
Cash equi prior fiscal year$0.00
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$0.00
Long term debt prior fiscal year$0.00
Net income most recent fiscal year-$219,362.00
Net income prior fiscal year$0.00
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$121,825
Short term debt prior fiscal year$0.00
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$162,194
Total asset prior fiscal year$0.00

Company Information

Corporation
NV
2017-07-27

Latest Metrics

Employees4
Total Assets$162,194
Cash on Hand$110,543
Revenues$0.00
Net Income-$219,362.00

Crowdfunding Portals

This company is raising funds through this portal